LYRA THERAPEUTICS INC
LYRA
LYRA was delisted on the 16th of March, 2026.
44 hedge funds and large institutions have $125M invested in LYRA THERAPEUTICS INC in 2023 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 7 reducing their positions, and 3 closing their positions.
15,983% more call options, than puts
Call options by funds: $965K | Put options by funds: $6K
233% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 3
114% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 7
19% more funds holding
Funds holding: 37 → 44 (+7)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
10% less capital invested
Capital invested by funds: $138M → $125M (-$13.6M)
41.4% less ownership
Funds ownership: 105.84% → 64.44% (-41%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IC
Ikarian Capital
Dallas,
Texas
|
+$987K |
| 2 |
Millennium Management
New York
|
+$942K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$572K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$540K |
| 5 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$331K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$8.81M |
| 2 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$1.48M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.25M |
| 4 |
Renaissance Technologies
New York
|
-$75.8K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$6.08K |
LYRA Hedge Fund Activity: Q3 2023 in Review
44 of the 6,311 institutional investors tracked by Wall St. Rank reported a position in LYRA THERAPEUTICS INC (LYRA) for Q3 2023, worth a combined $125M — down 9.8% from $138M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new LYRA positions and 3 closed out — a net gain of 7 holders — while 15 added to existing stakes and 7 trimmed.
The largest buyer was Ikarian Capital, adding an estimated $987K. The largest seller was Armistice Capital, cutting an estimated $8.81M.
- 44 institutional investors held LYRA THERAPEUTICS INC (LYRA) as of Q3 2023, up from 37 in Q2 2023.
- Funds reported $125M of LYRA THERAPEUTICS INC stock for Q3 2023, down 9.8% quarter-over-quarter.
- 10 funds opened new LYRA THERAPEUTICS INC positions in Q3 2023 and 3 closed out, a net change of +7 holders.
- The largest LYRA THERAPEUTICS INC buyer in Q3 2023 was Ikarian Capital, an estimated $987K added.
- The largest LYRA THERAPEUTICS INC seller in Q3 2023 was Armistice Capital, an estimated $8.81M sold.
Based on aggregated 13F filings for Q3 2023.